# VIMPAT
> **NDA022253** · New Drug Application · Sponsor: UCB INC · Approved 2008-10-28
## Drug
- **FDA Application Number:** NDA022253
- **Application type:** New Drug Application
- **Brand name:** VIMPAT
- **Generic name:** LACOSAMIDE
- **Active ingredients:** LACOSAMIDE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** UCB INC
- **Manufacturer:** UCB, Inc.
- **First approval:** 2008-10-28
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022253)
---
*MORVS · CC0 1.0*